Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-162
Tesamorelin 5 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-162
Active Batch Lot
GH Secretagogues & Growth Factors • In stock — Ready to ship

Tesamorelin (5 mg)

€58 5 mg • EUR

Tesamorelin is a full-length 44-amino acid human GHRH analogue stabilized at its N-terminus with a trans-3-hexenoic acid group to prevent DPP-4 cleavage while preserving native pituitary GHRH receptor kinetics.

Chemical & Registry Specifications
CAS Registry Number 218949-48-5
Molecular Formula C221H366N72O67S
Molecular Weight 5135.77 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class N-(trans-3-hexenoyl)-human GHRH(1-44)-NH2 (44-aa)
Primary Biological Target / Pathway Pituitary GHRH Receptor (full-length stabilized GHRH 1-44 analogue)
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: Tesamorelin

Tesamorelin is a full-length 44-amino acid human GHRH analogue stabilized at its N-terminus with a trans-3-hexenoic acid group to prevent DPP-4 cleavage while preserving native pituitary GHRH receptor kinetics.

Full 44-residue trans-3-hexenoyl-GHRH(1-44) (5135.77 Da)
Enhanced DPP-4 proteolytic resistance vs native GHRH
≥99.0% RP-HPLC purity & moisture verification
Primary Literature Reference Falutz J. et al., N Engl J Med (2007) — Metabolic effects of trans-3-hexenoyl GHRH(1-44) analogue Tesamorelin (PMID: 18057338)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-162)

Analytical release verification for current Tesamorelin (5 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-162 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.0% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)

Temperature & Stability

Store lyophilized at -20°C; refrigerate solution at 2°C–8°C for up to 21 days.

Tesamorelin — Technical Questions & Answers

What is the molar concentration when reconstituting Tesamorelin (5 mg) in 2.0 mL?

Reconstituting the full 5 mg vial of Tesamorelin (MW 5135.77 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.49 mM (487 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does Tesamorelin's counterion stoichiometry affect assay mass calculations?

Tesamorelin (CAS 218949-48-5, formula C221H366N72O67S) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify Tesamorelin Lot SL-2026-162 and what pathway does it target?

Lot SL-2026-162 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 5135.77 g/mol. In preclinical literature, Tesamorelin targets Pituitary GHRH Receptor (full-length stabilized GHRH 1-44 analogue) (Falutz J. et al., N Engl J Med (2007) — Metabolic effects of trans-3-hexenoyl GHRH(1-44) analogue Tesamorelin (PMID: 18057338)).

Research Use Only (RUO): Tesamorelin is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related GH Secretagogues & Growth Factors Compounds

View category →
≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 5 mg — ≥99.0% Research Vial
CJC-1295
5 mg In stock
CAS 863288-34-0 (with DAC)
MW: 3647.28 g/mol
€48
≥99.0%
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% Research Vial
CJC-1295 + Ipamorelin
5mg + 5mg In stock
CAS 863288-34-0 / 170851-70-4
MW: 3367.97 g/mol & 711.86 g/mol
€62

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog